Rapport Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $17M | 558k | 29.70 |
| 2025-06-30 | $3.1M | 274k | 11.37 |
| 2025-03-31 | $649k | 65k | 10.03 |
| 2024-12-31 | $378k | 21k | 17.74 |
| 2024-09-30 | $114k | 5.6k | 20.48 |
| 2024-06-30 | $73k | 3.1k | 23.26 |